Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


Articles published in Sex Transm Infect

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    September 2023
  1. DRUD ST, Anagrius C, Lore B, Elfving K, et al
    Changes in prevalence of Mycoplasma genitalium macrolide and fluoroquinolone resistance: notes from a 13-year retrospective survey in Dalarna County, Sweden.
    Sex Transm Infect. 2023 Sep 13:sextrans-2023-055900.
    PubMed     Abstract available


    August 2023
  2. SOKOLL PR, Migliavaca CB, Siebert U, Schmid D, et al
    Prevalence of Mycoplasma genitalium infection among HIV PrEP users: a systematic review and meta-analysis.
    Sex Transm Infect. 2023;99:351-359.
    PubMed     Abstract available


    May 2023
  3. GOODFELLOW JJ, Hughes S, Smith J, Jones R, et al
    Novel use of oral chloramphenicol for treatment-resistant Mycoplasma genitalium.
    Sex Transm Infect. 2023;99:208-210.
    PubMed     Abstract available


  4. VAN DIJCK C, Kenyon C
    No evidence of reduced cephalosporin susceptibility of circulating strains of Neisseria gonorrhoeae in the Netherlands despite nearly a decade of recommending ceftriaxone monotherapy.
    Sex Transm Infect. 2023;99:213-214.
    PubMed    


    September 2022
  5. PEREYRE S, Laurier-Nadalie C, Le Roy C, Guiraud J, et al
    Prevalence of macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in metropolitan and overseas France.
    Sex Transm Infect. 2022 Sep 5:sextrans-2022-055466.
    PubMed     Abstract available


    August 2022
  6. JONDUO ME, Vallely AJ, Whiley DM, Riddell MA, et al
    Mycoplasma genitalium macrolide and fluoroquinolone resistance in pregnant women in Papua New Guinea.
    Sex Transm Infect. 2022 Aug 4. pii: sextrans-2022-055552.
    PubMed    


    June 2022
  7. RACCAGNI AR, Bruzzesi E, Cernuschi M, Galli L, et al
    Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice.
    Sex Transm Infect. 2022 Jun 22. pii: sextrans-2022-055525.
    PubMed    


  8. SHIPITSYNA E, Khusnutdinova T, Budilovskaya O, Shedko E, et al
    Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M. genitalium resistance mutations in St.
    Sex Transm Infect. 2022 Jun 16. pii: sextrans-2021-055249.
    PubMed     Abstract available


  9. LATIMER RL, Vodstrcil LA, Plummer EL, Doyle M, et al
    The clinical indications for testing women for Mycoplasma genitalium.
    Sex Transm Infect. 2022;98:277-285.
    PubMed     Abstract available


    March 2022
  10. ALLEN H, Merrick R, Ivanov Z, Pitt R, et al
    Is there an association between previous infection with Neisseria gonorrhoeae and gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015-2019.
    Sex Transm Infect. 2022 Mar 4. pii: sextrans-2021-055298.
    PubMed     Abstract available


    November 2021
  11. NERI A, Palmieri A, Prignano G, Giuliani M, et al
    Molecular characterisation and antibiotic susceptibility of meningococcal isolates from healthy men who have sex with men.
    Sex Transm Infect. 2021 Nov 17. pii: sextrans-2021-055173.
    PubMed     Abstract available


    June 2021
  12. DAY MJ, Cole MJ, Fifer H, Woodford N, et al
    Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services.
    Sex Transm Infect. 2021 Jun 4. pii: sextrans-2020-054897.
    PubMed     Abstract available


  13. DE BAETSELIER I, Kenyon C, Vanden Berghe W, Smet H, et al
    An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018.
    Sex Transm Infect. 2021;97:297-303.
    PubMed     Abstract available


    March 2021
  14. SHILLING HS, Garland SM, Costa AM, Marceglia A, et al
    Chlamydia trachomatis and Mycoplasma genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009-2019.
    Sex Transm Infect. 2021 Mar 29. pii: sextrans-2020-054695.
    PubMed     Abstract available


  15. LAUMEN JGE, van Alphen LB, Maduna LD, Hoffman CM, et al
    Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa.
    Sex Transm Infect. 2021;97:152-156.
    PubMed     Abstract available


    February 2021
  16. BROAD CE, Furegato M, Harrison MA, Pond MJ, et al
    High prevalence of coinfection of azithromycin-resistant Mycoplasma genitalium with other STIs: a prospective observational study of London-based symptomatic and STI-contact clinic attendees.
    Sex Transm Infect. 2021;97:63-68.
    PubMed     Abstract available


    October 2020
  17. KAKOOZA F, Musinguzi P, Workneh M, Walwema R, et al
    Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda.
    Sex Transm Infect. 2020 Oct 20. pii: sextrans-2020-054581.
    PubMed     Abstract available


    September 2020
  18. RICHARDSON D, Lewis DA, Jeoffreys NJ, Couldwell DL, et al
    Mycoplasma genitalium coinfection in men with symptomatic gonococcal urethritis.
    Sex Transm Infect. 2020 Sep 10. pii: sextrans-2020-054529.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.